Thomas Cannell, EVP & CCO at Orexigen, holds 672.39K shares in Carisma Therapeutics (Ticker: CARM), holds 5.09K shares in Orexigen (Ticker: OREXQ). Most recently, Thomas Cannell Bought ― shares of Carisma Therapeutics on Mar 06, 2023 for an estimated value of 351.94K.